Thermal dephasing in second-harmonic generation of an amplified copper-vapor laser beam in beta barium borate

The conversion efficiency in second-harmonic generation of an amplified beam in a master-oscillator power amplifier copper-vapor laser (CVL) is lower than that of the oscillator beam alone. This lower efficiency is often vaguely attributed to wave-front degradation in the amplifier. We investigate the role of wave-front degradation and thermal dephasing in the second-harmonic generation of a CVL from a beta-barium borate crystal. Choosing two beams with constant intrapulse divergence, one from a generalized diffraction filtered resonator master oscillator alone and other obtained by amplifying oscillator by use of a power amplifier, we show that at low flux levels the decrease in efficiency is due to wave-front degradation. At a fundamental power above the critical power for thermal dephasing, the decrease is due to increased UV absorption and consequent thermal dephasing. Thermal dephasing is higher for the beam with the lower coherence width.     

Long-period gratings in planar optical waveguides

We present a theoretical analysis of light propagation in a four-layer planar waveguide that consists of a long-period grating (LPG) having a period of the order of 100 microm. By means of the coupled-mode theory, we show that such a structure is capable of coupling light from the fundamental guided mode to the cladding modes at specific wavelengths (resonance wavelengths) and thus results in sharp rejection bands in the transmission spectrum of the waveguide. Our numerical results show that the resonance wavelengths as well as the transmission spectrum can be significantly changed with the waveguide and grating parameters. A waveguide-based LPG should provide a useful approach to the design of a wide range of integrated-optic devices, including wavelength-tunable filters, switches, and environmental sensors.     

Thermal,morphological and spectroscopic studies on cellulose modified with phosphorus,nitrogen, sulphur and halogens

The kinetics of the thermal degradation of cellulose and modified cellulose, namely, cellulose phosphate, cellulose carbanilate, cellulose tosylate, chlorodeoxycellulose, bromodeoxycellulose, and iododeoxycellulose in air were studied by thermogravimetry and differential thermal analysis from ambient temperature to 700°C. The various thermodynamic functions for different stages of thermal degradation had been obtained following the procedure of Broido. The activation energies for the oxidative decomposition of cellulose and modified celluloses were found to be in the range 30–399 kJ mol^?1. The infrared spectra of the residues of modified celluloses gave indication of formation of a compound containing P?O, P? O? P (only in the case of cellulose phosphate), C?C, and C?O groups in the final residual char. The EPR signals indicated the formation of trapped and stable free radicals in the thermal degradation of all the compounds, particularly halodeoxycelluloses showed generation of large amounts of trapped free radicals during the oxidative decomposition. Scanning electron micrographs of the thermally degraded cellulose derivatives show changes in the fibrillar structure, evolution of gasesous products, and film formation depending upon the nature of the substituent in the cellulose matrix. The mechanism of thermal degradation of these compounds has been proposed.     

An experimental facility for determination of steady flame spread rate of materials employing the Quasi-stationary flame front technique

An experimental facility based on the Quasi-stationary Flame Front Technique for determination of steady flame spread rate of materials at discrete levels of external radiant heat flux was developed. The method employs an external radiant heat source in front of which an element of a specimen of the material is positioned at a location corresponding to the desired level of external radiant heat flux. A specimen movement assembly, which can be operated manually, was designed for moving the specimen towards the stationary external radiant heat source such that the flame front could be maintained quasi-stationary. The experimental technique employed is simple in operation yet is capable of yielding reliable flame fornt displacement–time data. In the paper the design considerations of the experimental facility, details of its components, calibration and typical experimental results obtained are presented.     

Single-pulse time-resolved comparative study on the performance of a master-oscillator,power-amplifier copper-vapor-laser system with generalized diffraction-filtered and unstable resonators as master oscillators

We present results of comparative time-resolved coherence studies on a single pulse from amaster oscillator power amplifier (MOPA) copper vapor laser with generalized diffraction-filtered and unstable resonators as master oscillators. It is shown that, unlike the conventionally used unstable-resonator MOPA reported in literature, the coherence of a generalized diffraction-filtered resonator MOPA pulse is fairly independent of the delay between the oscillator and the amplifier. It also remains constant throughout the pulse, with the result that the flux is constant over a large range of the delay.     

Analysis of HIV seropositive thalassemic children for antibodies specific to Aspergillus fumigatus by luminescent immunoassay

The applicability of luminescent immunoassay (LIA) in serodiagnosis of fungal infections in multitransfused (MT) thalassemic children seropositive for human immunodeficiency virus (HIV) was investigated. Thirty-one sera samples from HIV infected pediatric patients with thalassemia receiving repeated blood transfusions were analysed for the presence of antibodies specific to Aspergillus fumigatus by LIA. The LIA was standardized using well defined antigens of A. fumigatus. Ten out of 31 (32.2%) of the MT-HIV positive patients were found to have anti-Aspergillus antibodies in their sera by LIA. The ELISA could detect A. fumigatus specific antibodies in 25.8% (8 out of 31) of the patients. Thus, 20% more number of patients turned to be positive for aspergillosis by LIA as compared to ELISA. The difference was found to be statistically significant (p < 0.005). Of the MT-HIV negative patients only 1 out of 33 (3%) showed A. fumigatus specific antibodies by LIA and ELISA both. In age and sex matched control group (n = 25) none of the patients was found to be positive for antibodies to A. fumigatus. LIA was found to have better discriminatory value indicating, thereby, its utility in diagnosis of aspergillosis in compromised patients.     

Hybrid edge, gap and directly coupled triangular microstrip antenna

A new hybrid type of configuration has been investigated to obtain wider bandwidth. In the proposed configuration, two parasitic resonators are directly coupled to the nonradiating edges of a central patch through short sections of the micro-strip lines and a third parasitic resonator is gap-coupled with its radiating edge.     

A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells

A number of membrane-anchored cytokines and cytokine receptors are susceptible to yield soluble counterparts. Recently, peptide-hydroxamate metalloproteinase inhibitors have been reported to block the proteolytic processing of tumour necrosis factor (TNF)-alpha 55- and 75-kDa TNF receptors (TNF-R55 and TNF-R75), and interleukin (IL)-6R. In this report the authors studied the effect of an hydroxamate metalloproteinase inhibitor on the secretion of cytokines and the generation of cytokine soluble receptors by human myelomonoycytic cell lines and purified monocytes. Whereas secretion of cytokines lacking a transmembrane domain precursor (IL-1 alpha, IL-1 beta, IL-6 or IL-10) is either unaffected or augmented, shedding/secretion of transmembrane domain-containing cytokines and cytokine receptors [TNF-alpha, macrophage colony-stimulating factor (M-CSF), transforming growth factor (TGF)-alpha, stem cell factor (SCF), TNF-R55, TNF-R75, and IL-6R] was dramatically decreased in the presence of the metalloproteinase inhibitor. The diversity of sequences in the cleavage site of these proteins and differences found in the inhibitory concentration values suggest the existence of a metalloproteinase family displaying different substrate specificity. These results emphasize the important role of metalloproteinases as regulators of membrane expression and secretion of cytokines and cytokine receptors.     

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

We have investigated the effects of two fibric acid derivatives, bezafibrate mono (400 mg daily) and gemfibrozil (600 mg b.d.), in 29 patients with type IIb hyperlipoproteinaemia. All patients received placebo and each drug for 8 weeks in randomised order in a double-blind, cross-over study designed to evaluate any different effects of the drugs on serum lipoproteins, cholesteryl ester transfer protein (CETP), cholesteryl ester transfer activity (CETA), plasma fibrinogen, plasminogen activator inhibitor-I (PAI-1) or paraoxonase. Serum cholesterol decreased (P < 0.05) with gemfibrozil, but the effect of bezafibrate on serum cholesterol did not achieve statistical significance (placebo 8.34 +/- 1.05 (mean +/- S.D.), gemfibrozil 7.70 +/- 1.23 and bezafibrate 7.8 +/- 1.37 mmol/l). Both drugs decreased the serum triglyceride concentration (both P < 0.001) (placebo 4.39 (3.13-5.75) (median (interquartile range)), bezafibrate 2.26 (1.89-3.89) and gemfibrozil 2.00 (1.30-3.30) mmol/l) and very low density lipoprotein (VLDL) cholesterol (both P < 0.001) (placebo 1.18 (0.74-2.30), bezafibrate 0.59 (0.34-0.85) and gemfibrozil 0.48 (0.34-0.68) mmol/l). Discontinuous gradient ultracentrifugation (DGU) revealed that Sf 60-400 (large VLDL) decreased by more than 50% and Sf 20-60 (small VLDL) by more than 30% with each of the drugs (both P < 0.001), neither of which affected the composition of these lipoproteins. Gemfibrozil decreased the concentration of Sf 12-20 lipoprotein (intermediate density lipoprotein; IDL) by 23% (P < 0.01), whereas the effect of bezafibrate on this lipoprotein did not achieve statistical significance. Neither drug altered the concentration of apolipoprotein B or of total Sf 0-12 lipoproteins (low density lipoprotein, (LDL)). Both, however, significantly increased the quantity of free cholesterol in Sf 0-12 lipoproteins (P < 0.05). Overall the concentration of triglycerides decreased significantly in all lipoproteins isolated by DGU (Sf 0-12, Sf 12-20, Sf 20-60, Sf 60-400) on gemfibrozil treatment, but only in Sf 20-60 and Sf 60-400 on bezafibrate (all P < 0.05). Both drugs also increased serum high density lipoprotein (HDL) cholesterol (placebo 1.15 +/- 0.29, bezafibrate 1.27 +/- 0.38 (P < 0.01) and gemfibrozil 1.26 +/- 0.49 (P < 0.05) mmol/l) and HDL3 cholesterol concentration (placebo 0.59 +/- 0.12, bezafibrate 0.72 +/- 0.23 (P < 0.001) and gemfibrozil 0.70 +/- 0.24 (P < 0.01) mmol/l). Serum apolipoprotein A1 (apo A1) was increased (P < 0.05) by bezafibrate compared to gemfibrozil (placebo 103 +/- 26, bezafibrate 111 +/- 28 and gemfibrozil 102 +/- 25 mg/dl) and CETA from HDL to VLDL and LDL was decreased (P < 0.05) by bezafibrate compared to placebo, but the apparent decrease with gemfibrozil did not achieve statistical significance (placebo 39.6 +/- 17.7, bezafibrate 32.3 +/- 14.7 and gemfibrozil 33.8 +/- 15.0 nmol/ml/h). Neither drug affected the circulating concentration of CETP. Plasma fibrinogen was increased (P < 0.05) by gemfibrozil (placebo 4.16 (3.38-4.71) and gemfibrozil 4.65 (4.05-5.77) g/l) and was significantly lower (P < 0.001) on bezafibrate (3.60 (3.18-4.54) g/l) than on gemfibrozil treatment. There was a significant (P < 0.05) increase in PAI-1 activity with bezafibrate and a similar trend with gemfibrozil (placebo 41.2 (25.6-64.5), bezafibrate 50.5 (35.1-73.9) and gemfibrozil 48.5 (31.5-5.4 U/l). Neither fibrate influenced plasma concentrations of PAI-1 nor were the activities of lecithin:cholesterol acyl transferase or paraoxonase affected. The major difference in the action of the two drugs on lipoprotein metabolism was the greater effect of gemfibrozil in decreasing the overall serum concentration of Sf 12-20 lipoproteins and the triglycerides in Sf 12-20 and 0-12 lipoproteins. Bezafibrate, however, increased serum apo A1 concentration and significantly decreased CETA. The two drugs also had different effects on the plasma fibrinogen levels, which increased with gemfibrozil and tended to decrea